DARGER
"DARGER" is a word mark owned by Arnatar Therapeutics, filed at the USPTO on October 27, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 27, 2026
- Filed
- October 27, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50184507
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns DARGER
The owner and representative on file with the office.
Owner
Arnatar Therapeutics
San Diego, United States
Representative
Farah P Bhatti
What the mark covers
The products and services DARGER is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of renal, hepatic, cardiovascular, metabolic, neurological, and inflammatory diseases and disorders.; Therapeutic pharmaceutical for the treatment of genetic, renal, hepatic, cardiovascular, metabolic, neurological and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of genetic diseases and disorders
What has happened so far
Steps recorded by the USPTO, newest first.
- New application office supplied data entered
- Application filing receipt mailed
- New application entered
About DARGER
Who owns the trademark "DARGER"?
The USPTO trademark "DARGER" (application 50184507) is owned by Arnatar Therapeutics.
What is the status of "DARGER"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull DARGER and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a1829f-4961-73f2-9781-c7fd54b5ef20
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a1829f-4961-73f2-9781-c7fd54b5ef20",
"object": "trademark",
"mark_text": "DARGER",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50184507",
"filing_date": "2026-10-27",
"nice_classes": [
5
],
"owners": [
{
"name": "Arnatar Therapeutics",
"entity_id": null
}
]
}